These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9604777)

  • 1. Correlation between IL-12 and IL-2 blood levels in the metastatic neoplastic disease: a possible inhibitory feedback system regulating their secretion.
    Lissoni P; Rovelli F; Giani L; Fumagalli L; Meregalli S; Comi G; Merlini D
    J Biol Regul Homeost Agents; 1996; 10(4):92-4. PubMed ID: 9604777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy.
    Lissoni P; Mengo S; Mandalà M; Mauri E; Brivio F; Rovelli F; Confalonieri G; Longarini R; Bonfante A; Folli D; Meregalli S; Barni S; Tancini G; Giani L
    J Biol Regul Homeost Agents; 1998; 12(1-2):38-41. PubMed ID: 9677534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
    J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
    In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease.
    Lissoni P; Brivio F; Rovelli F; Fumagalli G; Malugani F; Vaghi M; Secondino S; Bucovec R; Gardani GS
    J Biol Regul Homeost Agents; 2000; 14(4):275-7. PubMed ID: 11215816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of erythrosedimentation rate in cancer in relation to cytokine production: correlation with high IL-6 and low IL-2 blood concentrations.
    Lissoni P; Brivio F; Pittalis S; Rovelli F; Rescaldani R; Perego MS; Grassi MG; Barni S; Tancini G; Majorca F; Fumagalli L
    J Biol Regul Homeost Agents; 1996; 10(2-3):60-2. PubMed ID: 9250887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of a normal endogenous secretion of interleukin-2 in metastatic cancer patients by a chronic subcutaneous injection of interleukin-2.
    Di Felice G; Fumagalli L; Majorca F; Barni S; Ardizzoia A; Tancini G; Lissoni P
    J Biol Regul Homeost Agents; 1996; 10(4):98-9. PubMed ID: 9604779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors.
    Lissoni P; Rovelli F; Tisi E; Brivio F; Ardizzoia A; Barni S; Tancini G; Saudelli M; Cesana E; Viganò MG
    J Biol Regul Homeost Agents; 1995; 9(4):146-9. PubMed ID: 8844339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients.
    Lissoni P; Fumagalli E; Malugani F; Ardizzoia A; Bucovec R; Tancini G; Gardani GS
    J Biol Regul Homeost Agents; 2001; 15(2):163-5. PubMed ID: 11501974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients.
    Messina G; Lissoni P; Bartolacelli E; Tancini G; Villa S; Gardani GS; Brivio F
    J Biol Regul Homeost Agents; 2003; 17(4):322-6. PubMed ID: 15065761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone.
    Lissoni P; Rovelli F; Baiocco N; Tangini G; Fumagalli L
    Anticancer Res; 2001; 21(1B):777-9. PubMed ID: 11299843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patients.
    Lissoni P; Barni S; Ardizzoia A; Scardino E; Tancini G; Viganò MG
    J Biol Regul Homeost Agents; 1995; 9(1):21-3. PubMed ID: 8553904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.
    Ardizzoia A; Lissoni P; Brivio F; Tisi E; Perego MS; Grassi MG; Pittalis S; Crispino S; Barni S; Tancini G
    J Biol Regul Homeost Agents; 1992; 6(3):103-7. PubMed ID: 1492596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems.
    Lissoni P; Messina G; Brivio F; Rovelli F; Di Fede G; Mainini E; Veronese E
    J Biol Regul Homeost Agents; 2005; 19(3-4):141-4. PubMed ID: 16602629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
    Brivio F; Lissoni P; Rovelli F; Nespoli A; Uggeri F; Fumagalli L; Gardani G
    Hepatogastroenterology; 2002; 49(44):385-7. PubMed ID: 11995457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 in early or advanced cancer patients.
    Lissoni P; Rovelli F; Pittalis S; Casati M; Perego MS; Grassi MG; Brivio F; Fumagalli L
    Eur J Cancer; 1997 Sep; 33(10):1703-5. PubMed ID: 9389937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-12 levels in patients with gastric cancer.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
    Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of surgery-induced IL-6 hypersecretion by presurgical immunotherapy with IL-2 and its importance in the prevention of postoperative complications.
    Brivio F; Lissoni P; Perego MS; Lissoni A; Fumagalli L
    J Biol Regul Homeost Agents; 2001; 15(4):370-4. PubMed ID: 11860226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptophol.
    Lissoni P; Pittalis S; Rovelli F; Zecchini S; Casati M; Tremolada M; Pelizzoni F
    J Biol Regul Homeost Agents; 1996; 10(1):27-30. PubMed ID: 9049779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.